Study of the Elevate Anterior and Apical Prolapse Repair System Compared to Native Tissue Repair for Pelvic Organ Prolapse
NCT ID: NCT02121977
Last Updated: 2016-09-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE4
285 participants
INTERVENTIONAL
2014-04-30
2019-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of the Elevate Apical and Posterior Prolapse Repair System Compared to Native Tissue Repair for Pelvic Organ Prolapse
NCT02123992
Pelvic Floor Repair Systems for Prolapse Repair
NCT00638235
Exair® Versus Native Tissue Repair for Prolapse
NCT02162628
Platelet Rich Plasma as an Adjunct Therapy at the Time of Transvaginal Native Tissue Prolapse Surgery
NCT05731284
ACell MatriStem Pelvic Floor Matrix Versus Native Tissue Repair, Comparative Study
NCT02021279
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Elevate Anterior and Apical
Prolapse repair with mesh
Elevate Anterior and Apical
Native Tissue Repair
Prolapse repair with sutures
Native Tissue Repair for pelvic organ prolapse
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Elevate Anterior and Apical
Native Tissue Repair for pelvic organ prolapse
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Subject must have documented diagnosis of anterior or anterior and apical vaginal prolapse with leading edge of pelvic organ prolapse at or beyond the hymen. At or beyond the hymen is defined as POP-Q scores of Ba ≥ 0; or Ba ≥ 0 and C ≥ -1/2 TVL (for a multi-compartment anterior prolapse that includes the apical compartment)
Subject reports a bothersome bulge they can see or feel per PFDI-20, question 3, response of 2 or higher (i.e., responses of "somewhat", "moderately", or "quite a bit")
Subject or subject's legally authorized representative is willing to provide written informed consent
Subject is willing and able to comply with the follow-up regimen
Exclusion Criteria
Subject has an active or chronic systemic infection including any gynecologic infection, untreated urinary tract infection (UTI) or tissue necrosis Subject has history of pelvic organ cancer (e.g. uterine, ovarian, bladder, or cervical)
Subject has history of pelvic organ cancer (e.g. uterine, ovarian, bladder, or cervical)
Subject has had prior or is currently undergoing radiation, laser therapy, or chemotherapy in the pelvic area
Subject has taken systemic steroids (within the last month), or immunosuppressive or immunomodulatory treatment (within the last 3 months)
Subject has systemic connective tissue disease (e.g. scleroderma, systemic lupus erythematosus (SLE), Marfan's syndrome, Ehlers Danhlos, collagenosis, polymyositis or polymyalgia rheumatica)
Subject has chronic systemic pain that includes the pelvic area or chronic focal pain that involves the pelvis
Subject has uncontrolled diabetes mellitus (DM)
Subject has a known neurologic or medical condition affecting bladder function (e.g., multiple sclerosis, spinal cord injury or stroke with residual neurologic deficit)
Subject is seeking obliterative vaginal surgery as treatment for pelvic organ prolapse (colpocleisis)
Subject is not able to conform to the modified dorsal lithotomy position
Subject is currently participating in or plans to participate in another device or drug study during this study
Subject has a known sensitivity to polypropylene
Subject has had previous prolapse repair with mesh in the target compartment
Subject is planning to undergo a concomitant repair with use of mesh in the non-target compartment
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
ASTORA Women's Health
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eric R Sokol, MD
Role: PRINCIPAL_INVESTIGATOR
Stanford University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Urological Associates of Southern Arizona
Tucson, Arizona, United States
Cedars-Sinai Medical Group
Beverly Hills, California, United States
The Clark Center for Urogynecology
Newport Beach, California, United States
Yale School of Medicine
New Haven, Connecticut, United States
National Center for Advanced Pelvic Surgery
Washington D.C., District of Columbia, United States
East Coast Institute for Research, LLC
Jacksonville, Florida, United States
Women's Health Advantage
Fort Wayne, Indiana, United States
Weinberg Center for Women's Health and Medicine
Baltimore, Maryland, United States
Chesapeake Urology
Owings Mills, Maryland, United States
Beaumont Health System
Royal Oak, Michigan, United States
Metro Urology
Woodbury, Minnesota, United States
Adult & Pediatric Urology and Urogynecology
Omaha, Nebraska, United States
Women's Cancer Center of Nevada
Las Vegas, Nevada, United States
Urogynecology & Pelvic Reconstructive Surgery - Atlantic Health System
Morristown, New Jersey, United States
Princeton Medical Center
Princeton, New Jersey, United States
Athena Women's Institute for Pelvic Health
Turnersville, New Jersey, United States
The Center for Specialized Women's Health
Whippany, New Jersey, United States
North Shore Women's Health Clinic
Great Neck, New York, United States
Premier Medical Group
Poughkeepsie, New York, United States
Seven Hills Woman's Health Center
Cincinnati, Ohio, United States
The Christ Hospital
West Chester, Ohio, United States
The Institute for Female Pelvic Medicine - St. Luke's Hospital
Allentown, Pennsylvania, United States
Center for Women's Health of Lansdale
Lansdale, Pennsylvania, United States
The Female Pelvic Health Center
Newtown, Pennsylvania, United States
Swan Urogynecology
Nashville, Tennessee, United States
University of Texas at Galveston
Galveston, Texas, United States
Lone Star Urogynecology and Continence Center
Round Rock, Texas, United States
Female Pelvic Medicine Institute of Virginia
North Chesterfield, Virginia, United States
Urology of Virginia, PLLC
Virginia Beach, Virginia, United States
Athena Women's Health
Issaquah, Washington, United States
University of Washington Pelvic Health Center
Seattle, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PR1205
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.